11 Paul Tudor Jones II AlloVir Trades
The first AlloVir trade was made in Q2 2021. Since then Paul Tudor Jones II bought shares four more times and sold shares on six occasions. The investor completely sold their stake between Q3 2023 and Q4 2024.
Avg closing price
Price range
Sold -2.16 Thousand shares
Q4 2024
Avg closing price
$2.20
Price range
$0.45
-
$10.91
Sold 32.6% shares (-1.04 Thousand shares)
Q3 2023
Avg closing price
$2.96
Price range
$2.15
-
$3.64
Increased shares by 175.2% (+2.04 Thousand shares)
Q2 2023
Avg closing price
$4.13
Price range
$3.17
-
$5.82
New holding (+1.16 Thousand shares)
Q1 2023
Avg closing price
$5.54
Price range
$3.94
-
$7.05
Sold -1.12 Thousand shares
Q4 2022
Avg closing price
$7.37
Price range
$4.70
-
$9.98
Sold 31.0% shares (-501 shares)
Q3 2022
Avg closing price
$6.78
Price range
$4.13
-
$8.79
Increased shares by 54.4% (+570 shares)
Q2 2022
Avg closing price
$4.56
Price range
$3.26
-
$7.06
Sold 2.3% shares (-25 shares)
Q1 2022
Avg closing price
$8.67
Price range
$6.75
-
$13.52
New holding (+1.07 Thousand shares)
Q4 2021
Avg closing price
$20.17
Price range
$12.94
-
$25.99
Sold -1.54 Thousand shares
Q3 2021
Avg closing price
$20.14
Price range
$16.97
-
$25.06
New holding (+1.54 Thousand shares)
Q2 2021
Avg closing price
$22.45
Price range
$19.44
-
$25.06
